Nanjing Pharmaceutical Company
1951
FOUNDED
PUBLIC
STATUS
1K-5K
EMPLOYEES
600713
STOCK SYMBOL
2
INVESTMENTS
$0.64
SHARE PRICE
(As of Friday Closing)
Description
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Primary Industry
Distributors/Wholesale (B2C)
Other Industries
Specialty Retail
Medical Supplies
Stock Exchange
SHG
Primary Office
- Number 486 Zhongshan East Road
- Nanjing, 210002
- China
+850 0000000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Nanjing Pharmaceutical Company’s full profile, request a free trial.
Nanjing Pharmaceutical Company Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.56 - $0.82 | $664M | $0.64 | $0.05 | 3.91M | 1.04B |
Nanjing Pharmaceutical Company Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 1,162,324 | 1,063,495 | 1,441,885 | 1,046,141 |
| Revenue | 5,198,261 | 4,731,931 | 4,263,167 | 4,011,587 |
| EBITDA | 140,240 | 132,374 | 115,592 | 95,767 |
| Net Income | 52,306 | 39,952 | 34,395 | 27,064 |
| Total Assets | 3,341,568 | 2,842,683 | 2,538,991 | 2,010,691 |
| Total Debt | 810,336 | 441,212 | 793,727 | 254,760 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Nanjing Pharmaceutical Company Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Nanjing Pharmaceutical Company‘s full profile, request access.
Request full access to PitchBookNanjing Pharmaceutical Company Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000000 0 | 25-Jul-2017 | 000000000 00000000 | Pharmaceuticals | ||
| Fujian Southeast Pharmaceutical | Merger/Acquisition | Pharmaceuticals |
Nanjing Pharmaceutical Company Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Nanjing Pharmaceutical Company‘s full profile, request access.
Request full access to PitchBookNanjing Pharmaceutical Company Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Yu Liang | President & Director | ||
| Wei Li | Chief Financial Officer | ||
| Xiao Jiang | Chief Operating Officer & Secretary | ||
| Jian Tang | Chief Quality Control Officer |